The Covid-19 vaccine will be offered first to healthcare workers, frontline workers and to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities based on the evolving pandemic situation, and finally to the remaining population based on the disease epidemiology and vaccine availability.
At the vaccination site, only pre-registered beneficiaries will be vaccinated in accordance with the prioritisation, and there will be no provision for on-the-spot registrations.
Under phase one of the vaccination, it is planned to vaccinate nearly 30 crore population.

“The dry swab testing method will be a game-changer in testing during the Covid-19 pandemic. The method is safer, faster and cheaper than the current testing method without compromising the quality of test results,” Rakesh Mishra, Director, CSIR-CCMB was quoted as saying in a statement.

He took the opportunity to caution people against letting the guard down before antibodies are created and second dose of the vaccine administered.